ApprovalTrail

Ingredient

Beclomethasone Dipropionate

Products in Health Canada’s databases that list Beclomethasone Dipropionate as a medicinal or active ingredient. Its salts and forms that the databases name on their own have their own pages.

Drug products
35
8 authorized now
Natural health products
0
0 active licences
Notices of Compliance
34
Products in all
35

Drug products

Authorized products first.

NameDINStatus
APO-BECLOMETHASONE NASAL SPRAY (50 MCG)Apotex Inc. · Status since Oct 199802238796Marketed
MYLAN-BECLO AQ (50 MCG)Mylan Pharmaceuticals Ulc · Status since Jun 201002172712Marketed
PROPADERM (0.025 %)Bausch Health, Canada Inc. · Status since Dec 202002089602Marketed
QVAR (50 MCG)Bausch Health, Canada Inc. · Status since Jan 202102242029Marketed
QVAR (100 MCG)Bausch Health, Canada Inc. · Status since Jan 202102242030Marketed
TRIMBOW (100 MCG)Chiesi Farmaceutici S.P.A. · Status since Sep 202602557592Marketed
BECLOMETHASONE NASAL SPRAY (50 MCG)Apotex Inc. · Status since Sep 202002238577Approved
RIVANASE AQ.NASAL SPRAY 50MCG/METERED DOSE (50 MCG)Laboratoire Riva Inc. · Status since Jul 201702228300Dormant
ALTI-BECLOMETHASONE DIPROPIONATE INHALER 50MCG/MD (50 MCG)Altimed Pharma Inc. · Status since May 200500872334Cancelled Post Market
BECLODISK - PWR INH 100MCG/BLISTER (100 MCG)Glaxo Wellcome Inc. · Status since May 200002213710Cancelled Post Market
BECLODISK - PWR INH 200MCG/BLISTER (200 MCG)Glaxo Wellcome Inc. · Status since May 200002213729Cancelled Post Market
BECLODISK PWR 100MCG/BLISTER (100 MCG)Glaxo Canada Inc · Status since Jul 199800828521Cancelled Post Market
BECLODISK PWR 200MCG/BLISTER (200 MCG)Glaxo Canada Inc · Status since Jul 199800828548Cancelled Post Market
BECLOFORTE 250MCG/AEM (250 MCG)Glaxo Canada Inc · Status since Jul 199800897353Cancelled Post Market
BECLOFORTE INHALER - AEM INH 250MCG/AEM (250 MCG)Glaxo Wellcome Inc. · Status since May 200002215055Cancelled Post Market
BECLOMETHASONE AQUEOUS NASAL SPRAY 50MCG/METERED DOSE (50 MCG)Prempharm Inc. · Status since Aug 200502229998Cancelled Post Market
BECLOMETHASONE DIPROPIONATE NAS-SPR 50MCG/AEM (50 MCG)Kenral Inc. · Status since Aug 199700872326Cancelled Post Market
BECLOMETHASONE DIPROPIONATE NASAL INHALER (50 MCG)Pharmaco Canada Inc. · Status since Jul 200102079984Cancelled Post Market
BECLOMETHASONE DIPROPIONATE ORAL INHALER (50 MCG)Pharmaco Canada Inc. · Status since Jul 200102079976Cancelled Post Market
BECLOVENT - AEM 50MCG/AEM (50 MCG)Glaxo Wellcome Inc. · Status since May 200002216531Cancelled Post Market
BECLOVENT AEM 50MCG/AEM (50 MCG)Glaxo Canada Inc · Status since Jul 199800893633Cancelled Post Market
BECLOVENT ROTACAPS - INH 100MCG/CAPSULE (100 MCG)Glaxo Wellcome Inc. · Status since May 200002215039Cancelled Post Market
BECLOVENT ROTACAPS - INH 200MCG/CAP (200 MCG)Glaxo Wellcome Inc. · Status since May 200002215047Cancelled Post Market
BECLOVENT ROTACAPS 100MCG (100 MCG)Glaxo Canada Inc · Status since Aug 200001949993Cancelled Post Market
BECLOVENT ROTACAPS 200MCG (200 MCG)Glaxo Canada Inc · Status since Jul 199801950002Cancelled Post Market
BECONASE AQ NASAL AEM 50MCG/AEM (50 MCG)Glaxo Canada Inc · Status since May 200001923935Cancelled Post Market
BECONASE NASAL AEM 50MCG/AEM (50 MCG)Glaxo Canada Inc · Status since Sep 199601923242Cancelled Post Market
PROPADERM CREAM 0.025% (.025 %)Allen & Hanburys A Glaxo Canada Ltd. Co. · Status since Jul 199800002712Cancelled Post Market
PROPADERM LOT 0.025% (.025 %)Allen & Hanburys A Glaxo Canada Ltd. Co. · Status since Sep 199600270466Cancelled Post Market
PROPADERM LOTION 0.025% (0.025 %)Shire Biochem Inc. · Status since Dec 200502089610Cancelled Post Market
QNASL (40 MCG)Teva Canada Limited · Status since Nov 202302446324Cancelled Pre Market
QNASL (80 MCG)Teva Canada Limited · Status since Nov 202302446332Cancelled Pre Market
RATIO-BECLOMETHASONE AQ (50 MCG)Ratiopharm Inc Division Of Teva Canada Limited · Status since May 201000872318Cancelled Post Market
VANCENASE AER 50MCG (50 MCG)Schering-Plough Canada Inc. · Status since Jul 200100422053Cancelled Post Market
VANCERIL AEM 50MCG (50 MCG)Schering-Plough Canada Inc. · Status since Jul 200400374407Cancelled Post Market

Notices of Compliance

Approvals of drug submissions that list it, newest first.